Journal of Biotechnology & Biomaterials
Like us on:
Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Plant made biologics have elicited much attention over recent years for their potential in assisting those in developing
countries who have poor access to modern medicine. Additional applications such as the stockpiling of vaccines against
pandemic infectious diseases or potential biological warfare agents are also under investigation. Plant virus expression vectors
represent a technology that enables high levels of pharmaceutical proteins to be produced in a very short period of time. Recent
advances in research and development have brought about the generation of superior virus expression systems which can be
readily delivered to the host plant in a manner that is both efficient and cost effective. The following presentation describes
recent innovations in plant virus expression systems and their uses for producing biologics from plants.
Kathleen L Hefferon received her PhD in Molecular Virology at the University of Toronto. She worked as a post-doc at the Boyce Thompson Institute for Plant
Research and later as the Director of the Human Metabolic Research Unit in the Division of Nutritional Science at Cornell University. Most recently, she has written
two books on agricultural biotechnology and is currently teaching Virology at the University of Toronto.
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals